Back |
home / stock / aplt / aplt message board
Subject | By | Source | When |
---|---|---|---|
When is this gonna take off? | 81vette | investorshub | 03/30/2023 10:34:08 PM |
Buy rating $23-$29 Citigroup,the Barclays $7-$9 is more | 81vette | investorshub | 02/16/2023 9:11:48 PM |
Pps above 200ma,golden cross coming ,greatest long chart | 81vette | investorshub | 02/16/2023 8:53:38 PM |
Look at what happens with green vol on | 81vette | investorshub | 02/16/2023 8:09:35 PM |
Trading natural/no naked shorting atm | 81vette | investorshub | 02/16/2023 8:04:11 PM |
Pre mkt today$1.40ish/$1.25ave,tonight and tomorrow continues up as | 81vette | investorshub | 02/16/2023 8:02:16 PM |
Looking good for week long run like in | 81vette | investorshub | 02/16/2023 7:58:00 PM |
znewcar1: APLT 1% v236K c2.00 f26,2M h2.045 not al of vol. yet seems to flattened out | znewcar1 | investorshangout | 04/29/2022 2:57:08 AM |
znewcar1: APLT 28% v946K c2.60 f26,2M H2.65 ML=LL1.45 | znewcar1 | investorshangout | 03/25/2022 2:57:25 AM |
News, Short Squeeze, Breakout and More Instantly...
Applied Therapeutics Inc. Company Name:
APLT Stock Symbol:
NYSE Market:
Applied Therapeutics Inc. Website:
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Govorestat NDA for Classic Galactosemia under Priority Review, PDUFA target action date of November 28, 2024 Govorestat MAA under review by EMA; Day 120 3-month clock-stop extension granted; decision expected in early Q1 2025 Company discussing potential NDA submission under...